Flashpoint Batley: Anti-racism protesters hold rally against...

Nicholas Hewlett, head of St Dunstan's College private school in southeast London, said staff were worried by a 'righteous generation' of children who were looking for their teachers to 'trip up' on even 'small, persistent slights'.

Although the company will continue to pursue "higher-risk, high reward" drug candidates such as pegilodecakin, these will be a smaller part of the portfolio in the future, said Chief Scientific Officer Daniel Skovronsky.

Flair also analysed dozens of open letters published by alumnae of private schools who complained last year about racist abuse they had endured in schools and a lack of black role models among teachers.

Nicholas Hewlett, head of St Dunstan's College private school in southeast London, said staff were worried by a 'righteous generation' of children who were looking for their teachers to 'trip up' on even 'small, persistent slights'.

In the UK, the pandemic and a crackdown on immigration following Brexit contributed to unpredictable supplies of fruits, vegetables and prepared foods in stores and restaurant chains, said Shane Brennan, chief executive at the Cold Chain Federation.

Although the company will continue to pursue "higher-risk, high reward" drug candidates such as pegilodecakin, these will be a smaller part of the portfolio in the future, said Chief Scientific Officer Daniel Skovronsky.

The teams' former medic, who is currently facing a fit-to-practise tribunal, paints a stark picture of the gold-medal factory across 66 pages of eye-opening claims within his written defence, which was disclosed over the weekend.

Although the company will continue to pursue "higher-risk, high reward" drug candidates such as pegilodecakin, these will be a smaller part of the portfolio in the future, said Chief Scientific Officer Daniel Skovronsky.

Although the company will continue to pursue "higher-risk, high reward" drug candidates such as pegilodecakin, these will be a smaller part of the portfolio in the future, said Chief Scientific Officer Daniel Skovronsky.